In addition, Dnmt1 was shown to have cancer-specific de novo activity in a mouse model of MYC-induced T cell lymphomas [5], whereas Dnmt3a and Dnmt3b were primarily involved in maintenance methylation in tumors [6,7]. The gene discussed is DNMT3A; the disease is T-cell non-Hodgkin lymphoma.